Occudo Quantitative Strategies LP Clene Inc. Transaction History

Occudo Quantitative Strategies LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.1 - $4.12 $32,274 - $63,320	-15,369 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.42 - $4.42 $1,851 - $3,381	-765 Reduced 4.74%	15,369 $61,000
Q4 2021 Feb 14, 2022	BUY	$3.95 - $7.53 $63,729 - $121,489	16,134 New	16,134 $66,000

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $279M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.